Nuvation Bio Inc. Balance Sheet
NUVB / Health Care|6 years of annual SEC 10-K data (FY2020-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 6 fiscal years. All figures from audited SEC 10-K filings.
Nuvation Bio Inc. had $595M in total assets and $306M in shareholders' equity as of FY2025. Total debt was $47M against $164M in cash, resulting in a $117M net cash position.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -1.56 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $164.1M | $35.7M | $42.6M | $101.1M | $132.4M | $29.8M |
| Accounts Receivable | $16.1M | $12.7M | $0 | - | - | - |
| Inventory | $11.4M | $0 | - | - | - | - |
| Current Assets | $571.5M | $526.3M | $616.4M | $667.3M | $772.1M | $220.7M |
| PP&E (Net) | $564.0K | $586.0K | $717.0K | $894.0K | $786.0K | $688.0K |
| Total Assets | $594.8M | $540.6M | $621.5M | $672.1M | $776.2M | $221.8M |
| Current Liabilities | $82.2M | $58.2M | $14.0M | $13.2M | $16.9M | $6.6M |
| Total Debt | $47.2M | - | - | - | - | - |
| Shareholders' Equity | $305.7M | $463.8M | $605.1M | $655.1M | $746.0M | $215.1M |